Zyvox Injection
Product Images NDC 66298-7807

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zyvox (NDC 66298-7807). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hp Halden Pharma As, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label4 (Label4)

Label for Zyvox 600 mg/300 mL (Linezolid) injection, intravenous use. The label shows the product as 10 IV bags of 300 mL each. It is manufactured by Premier and distributed by Pharmacia & Upjohn Co, a division of Pfizer Inc. Storage instructions indicate controlled room temperature with no freezing. The label includes multiple barcodes and placeholders for expiration date, lot number, and quantity.*

FDA Label Image

Chemical Structure (Zyvox 01)

Chemical structure of linezolid, the active ingredient in Zyvox injection 600 mg/300 mL by Hp Halden Pharma AS. The diagram shows the molecular arrangement and bonds characteristic of linezolid.*

FDA Label Image

Figure 1 (Zyvox 02)

A line graph depicting linezolid plasma concentration (µg/mL) over time (hours) after a 600 mg oral dose every 12 hours. The graph shows concentration peaks shortly after dosing followed by a gradual decline up to 12 hours, with error bars indicating variability.*

FDA Label Image

Chemical Structure (Zyvox 03)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.